The patient data are consistent with a previous report showing that CD161hi CD8+ T cells are reduced in patients with a variety of rheumatic diseases including SLE, MCTD (mixed connective-tissue disease), SSc (systemic sclerosis) and PM/DM (polymyositis/dermatomyositis) [45]. Here, CD8A is linked to rheumatic disorder.